Cell Kinetics and Rikaken sign distribution agreement

Cell Kinetics an indirect majority-owned subsidiary of Medis Technologies, is developing and will market a series of products, based on its Cell Carrier technology, under the CKChip trade name. The CKChip can accommodate up to 10,000 cells on individual wells for measuring reactions of living cells in a static state over time, using simple imaging methods such as fluorescence microscopy.

Yoshio Morikawa, president of Rikaken, said: “The CKChip is a unique new technology for single cell research, in particular for acquisition of kinetic data, and we believe that the CKChip has various research and, ultimately, clinical applications. This contract with Cell Kinetics adds an important dimension to our management strategy, and we are very excited to be able to provide this new product offering to our established customer base, as well as see this as allowing us to expand that base even further.”